UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment

BMJ evidence-based medicine, 2019-10, Vol.24 (5), p.177-184

2019

Volltextzugriff (PDF)

Activation of 5-HT6 receptors facilitates attentional set shifting

Psychopharmacologia, 2010-01, Vol.208 (1), p.13-21

2010

Volltextzugriff (PDF)

In vitro and in vivo characterization of the non-peptide NK3 receptor antagonist SB-223412 (talnetant): potential therapeutic utility in the treatment of schizophrenia

Neuropsychopharmacology (New York, N.Y.), 2008-06, Vol.33 (7), p.1642-1652

2008

Volltextzugriff (PDF)

A comparison of possible markers for chandelier cartridges in rat medial prefrontal cortex and hippocampus

Brain research, 2005-01, Vol.1031 (2), p.238-244

2005

Volltextzugriff (PDF)

Comparative effects of some nitric oxide donors on cyclic GMP levels in rat cerebellar slices

Neuroscience letters, 1991-09, Vol.130 (1), p.107-111

1991

Volltextzugriff (PDF)

GSK189254, a Novel H 3 Receptor Antagonist That Binds to Histamine H 3 Receptors in Alzheimer's Disease Brain and Improves Cognitive Performance in Preclinical Models

The Journal of pharmacology and experimental therapeutics, 2007-06, Vol.321 (3), p.1032-1045

2007

Volltextzugriff (PDF)

Effect of lamotrigine on the activities of monoamine oxidases A and B in vitro and on monoamine disposition in vivo

European journal of pharmacology, 2005-09, Vol.519 (3), p.237-245

2005

Volltextzugriff (PDF)

GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models

The Journal of pharmacology and experimental therapeutics, 2007-06, Vol.321 (3), p.1032

2007

Volltextzugriff (PDF)

Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one

Molecular pharmacology, 1995-08, Vol.48 (2), p.184-188

1995

Volltextzugriff (PDF)

Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040

Psychopharmacologia, 2009, Vol.201 (4), p.483-494

2009

Volltextzugriff (PDF)

Increased expression of the NR2A NMDA receptor subunit in the prefrontal cortex of rats reared in isolation

Synapse (New York, N.Y.), 2009-10, Vol.63 (10), p.836-846

2009

Volltextzugriff (PDF)

Chandelier cartridges in the prefrontal cortex are reduced in isolation reared rats

Synapse (New York, N.Y.), 2008-08, Vol.62 (8), p.628-631

2008

Volltextzugriff (PDF)

Reversal of isolation-rearing-induced PPI deficits by an alpha 7 nicotinic receptor agonist

Psychopharmacology, 2005-10, Vol.182 (2), p.214-219

2005

Volltextzugriff (PDF)

Reversal of isolation-rearing-induced PPI deficits by an α7 nicotinic receptor agonist

Psychopharmacologia, 2005-10, Vol.182 (2), p.214-219

2005

Volltextzugriff (PDF)

Activation of 5-HT sub(6) receptors facilitates attentional set shifting

Psychopharmacology, 2010-01, Vol.208 (1), p.13-21

2010

Volltextzugriff (PDF)

Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats

European journal of pharmacology, 1998-09, Vol.358 (1), p.19-24

1998

Volltextzugriff (PDF)

Effect of the selective dopamine D 3 receptor antagonist SB-277011-A on regional c-Fos-like expression in rat forebrain

Brain research, 2007-05, Vol.1149, p.50-57

2007

Volltextzugriff (PDF)

Effect of the selective dopamine D3 receptor antagonist SB-277011-A on regional c-Fos-like expression in rat forebrain

Brain research, 2007-05, Vol.1149, p.50-57

2007

Volltextzugriff (PDF)

In vitro and in vivo comparison of two non-peptide tachykinin NK3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristics

European journal of pharmacology, 2010-02, Vol.627 (1-3), p.106-114

2010

Volltextzugriff (PDF)

In vitro and in vivo characterization of PheTQS, a novel α7 nAChR positive allosteric modulator

Biochemical pharmacology, 2009-10, Vol.78 (7), p.913-913

2009

Volltextzugriff (PDF)

In vitro and in vivo comparison of two non-peptide tachykinin NK sub(3) receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristics

European journal of pharmacology, 2010-02, Vol.627 (1-3), p.106-114

2010

Volltextzugriff (PDF)

In vitro and in vivo comparison of two non-peptide tachykinin NK 3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristics

European journal of pharmacology, 2010, Vol.627 (1), p.106-114

2010

Volltextzugriff (PDF)

Reversal of isolation-rearing-induced PPI deficits by an [alpha]7 nicotinic receptor agonist

Psychopharmacology, 2005-10, Vol.182 (2), p.214

2005

Volltextzugriff (PDF)

Reversal of isolation-rearing-induced PPI deficits by an alpha7 nicotinic receptor agonist

Psychopharmacology, 2005-10, Vol.182 (2), p.214-219

2005

Volltextzugriff (PDF)

Sources and targets of nitric oxide in rat cerebellum

Neuroscience letters, 1992-03, Vol.137 (2), p.241-244

1992

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(44)
Buchkapitel
(2)

Sprache

Englisch
(46)

Erscheinungsjahr

n.n

Thema

Science & Technology
(24)
Life Sciences & Biomedicine
(21)
Animals
(20)
Rats
(16)
Biological And Medical Sciences
(13)
Male
(12)
Neurosciences
(12)
Neurosciences & Neurology
(11)
Humans
(9)
Pharmacology & Pharmacy
(9)
Medical Sciences
(7)
Cyclic Gmp - Metabolism
(6)
Fundamental And Applied Biological Sciences. Psychology
(6)
Schizophrenia
(6)
Brain - Drug Effects
(5)
Cyclic Gmp
(5)
In Vitro Techniques
(5)
Microdialysis
(5)
Pharmacology. Drug Treatments
(5)
Psychology. Psychoanalysis. Psychiatry
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment

Activation of 5-HT6 receptors facilitates attentional set shifting

In vitro and in vivo characterization of the non-peptide NK3 receptor antagonist SB-223412 (talnetant): potential therapeutic utility in the treatment of schizophrenia

A comparison of possible markers for chandelier cartridges in rat medial prefrontal cortex and hippocampus

Comparative effects of some nitric oxide donors on cyclic GMP levels in rat cerebellar slices

GSK189254, a Novel H 3 Receptor Antagonist That Binds to Histamine H 3 Receptors in Alzheimer's Disease Brain and Improves Cognitive Performance in Preclinical Models

Effect of lamotrigine on the activities of monoamine oxidases A and B in vitro and on monoamine disposition in vivo

GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models

Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one

Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040

Increased expression of the NR2A NMDA receptor subunit in the prefrontal cortex of rats reared in isolation

Chandelier cartridges in the prefrontal cortex are reduced in isolation reared rats

Reversal of isolation-rearing-induced PPI deficits by an alpha 7 nicotinic receptor agonist

Reversal of isolation-rearing-induced PPI deficits by an α7 nicotinic receptor agonist

Activation of 5-HT sub(6) receptors facilitates attentional set shifting

Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats

Effect of the selective dopamine D 3 receptor antagonist SB-277011-A on regional c-Fos-like expression in rat forebrain

Effect of the selective dopamine D3 receptor antagonist SB-277011-A on regional c-Fos-like expression in rat forebrain

In vitro and in vivo comparison of two non-peptide tachykinin NK3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristics

In vitro and in vivo characterization of PheTQS, a novel α7 nAChR positive allosteric modulator

In vitro and in vivo comparison of two non-peptide tachykinin NK sub(3) receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristics

In vitro and in vivo comparison of two non-peptide tachykinin NK 3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristics

Reversal of isolation-rearing-induced PPI deficits by an [alpha]7 nicotinic receptor agonist

Reversal of isolation-rearing-induced PPI deficits by an alpha7 nicotinic receptor agonist

Sources and targets of nitric oxide in rat cerebellum

Aktive Filter

Suchergebnisse filtern